|
|
|
|
|
|
BioEnterprise Team
|
|
|
Management | Associates | Board | Partners
.jpg) |
Baiju R. Shah,
President & CEO
Baiju R. Shah is President and CEO and a Founder of BioEnterprise. He focuses on BioEnterprise's strategic initiatives as well as counseling clients on business and financial matters. Prior to BioEnterprise, Shah was with McKinsey & Company, where he played a leading role in the Growth and Business Building practice. Shah is on the Board of Directors of Invacare (NYSE) and on the advisory boards of Charter One and Cleveland International Fund. In the community, Shah is Chair of Global Cleveland and serves on the boards of Great Lakes Science Center, Saint Luke's Foundation, and United Way of Greater Cleveland. Shah received a J.D. from Harvard and his B.A. from Yale.
Click to download photo
Click to download short biography
Click to download full biography
|
 |
Annette Ballou,
Director, Strategic Marketing & Communications
Annette Ballou leads strategic marketing for BioEnterprise, helping the initiative and its companies in market positioning, message definition, and communication strategy. Ballou has over 20 years of experience in health care marketing and business development in a range of private companies. She has expertise in strategic planning and implementation, business development, marketing, communications and operations, Ballou received her J.D. from Southern Methodist University as well as a B.A. in English and a B.S. in Psychology.
Click to download photo
|
|
Photo
Coming
Soon
|
Jen Boland,
CEO-in-Residence
Jen Boland focuses on the development of new biomedical ventures. She has extensive experience in launching and funding high growth ventures. At Cleveland Clinic, Boland assisted spinoff companies by advising companies on raising financing, negotiating licensing agreements, and managing first generation products through design freeze and regulatory submission. Prior to joining Cleveland Clinic, she was responsible for the financial planning and analysis of several business operations within LeapFrog, a venture-backed technology company located in the Bay Area. Her experience also includes roles with a start-up venture within Hewlett-Packard and with an All-American ranked equity research team at Deutsche Banc Alex. Brown. Boland received her MBA from the UC Berkeley Haas School of Business and her BA in Economics from the University of Vermont.
|
 |
Carol Clark,
Vice President
Carol Clark leads the company’s effort for advising growth stage health care opportunities including acquisition-based strategies and is also Managing Director of the Medical Growth Fund. Clark brings 20 years of experience in structuring and syndicating leveraged buyouts, acquisition financings and business expansion facilities at the Bank of Boston and Aetna Life & Casualty. Recently she was involved as a founding officer and Board member of NineSigma, a Cleveland-based technology start-up. She served as the company's CFO and was a key member of the private equity fund raising team. Currently she serves on the Industry Advisory Board for the Cornell Center for Technology Enterprise and Commercialization. Clark, a CFA, received an M.B.A. from Cornell University and B.A. from Wesleyan University.
Click to download photo
|
 |
Russ Donda,
Entrepreneur in Residence, Biosensors
Russ Donda is currently serving as the Entrepreneur in Residence for biosensor technologies at BioEnterprise and the Great Lakes Innovation & Development Enterprise. He has over 25 years of management experience at both executive and entrepreneurial levels, with a background in very early stage companies. Russ is familiar with start-up operations, strategic planning, development related issues, marketing, patent law, intellectual property management, and strategic alliance structuring. He was the founding CEO of ViewRay Incorporated, a founding manager at Regeneration Technologies, and a founding member and co-chair of investment review for the angel group, The Emergent Growth Fund.
Click to download photo
|
Photo
Coming
Soon |
Brian Duncan, M.D., M.B.A.,
Vice President
Brian Duncan, M.D., is a Vice President on the medical devices team at BioEnterprise and is also the Ohio Venture Partner for Arboretum Ventures. Duncan is a cardiac surgeon who has more than 20 years of clinical experience. After completing training at Massachusetts General Hospital, he was a staff surgeon at Children’s Hospital in Boston, Seattle Children’s Hospital and Cleveland Clinic. Duncan also has experience developing pediatric ventricular assist devices. Most recently, Duncan was the Medical Director for Cleveland Clinic Emerging Businesses Unit. He has authored more than 100 peer-reviewed manuscripts, 25 book chapters, and the definitive textbook on pediatric circulatory support entitled Mechanical Support for Cardiac and Respiratory Failure in Pediatric Patients. He serves on the boards of BioOhio, American Society for Artificial Internal Organs and Accord Biomaterials. Duncan received his B.S. and M.D. degrees from Indiana University and also has an M.B.A. from the University of Michigan.
|
|
 |
Glen Gaughan, Ph.D.,
CEO-in-Residence
Glen Gaughan focuses on developing and supporting biopharmaceutical companies for BioEnterprise. He works closely with a number of the companies, supporting the development of their business strategies and operating plans. Gaughan has almost 20 years of experience as a drug discovery scientist with Bristol-Myers Squibb. In roles ranging from Principal Investigator to Group Leader, he contributed to programs searching for new medications for pain, obesity, sleep disorders, and depression, and for contrast agents for MRI. Gaughan designed ProHance, an MRI contrast agent marketed by Bracco. Gaughan holds a Ph.D. in Chemistry from the University of Oregon, an MBA from Case Western Reserves, and a B.A. from Dartmouth.
Click to download photo
|
 |
Margaret E. Groh, Ph.D.,
Director, Business Development
Meg Groh focuses on business development for biopharmaceutical companies and also oversees the due diligence process for new opportunities. She has extensive research experience at the Jefferson Institute of Molecular Medicine, Howard Hughes Medical Institute, the University of Chicago and Case Western Reserve University. Her work covered several areas of molecular medicine including lipid metabolism, molecular cardiology, and stem cell biology. Groh received a Ph.D. from the University of Chicago, a B.S. from Tulane University and an M.B.A. from Case Weatherhead School of Management.
Click to download photo
|
.jpg) |
Al Hawkins,
CEO-in-Residence
Al Hawkins is focused on developing new biomedical companies based on technologies licensed from universities, hospitals and federal labs. Hawkins was formerly Director of New Ventures at Boston University (BU), where he led the process of developing early stage companies based on the institution’s research base. Hawkins managed BU’s seed investment fund, recruited senior management to early-stage opportunities, managed an incubator and BU’s mentorship program. Prior to BU, Hawkins was a founder and Partner in Agave Group, a Madison, Wisconsin-based consulting firm dedicated to early stage life science companies and investors. He serves as an SBIR grant reviewer for NIH and has served on the boards of several private companies and nonprofits. Hawkins received a B.A. from Emory University, an M.B.A. from the University of Wisconsin-Madison, and an M.S. in Health Sciences and Technology from MIT.
|
 |
Bob Johnson,
Vice President
Bob Johnson is a leader of the medical devices team at BioEnterprise. He has an extensive background in the medical device industry across many functions including new ventures, marketing and business development. Johnson has commercialized devices, instrumentation, and diagnostic technologies for cardiology, radiology, obstetrics/gynecology, pulmonology and urology applications. In addition, he has completed numerous transactions including financings, acquisitions, licenses and strategic alliances in his work. Throughout his career, Mr. Johnson has worked in executive capacities for medical device companies including C.R. Bard, Respironics, and Mallinckrodt. Johnson has a B.S. in Business Administration from Loyola University in Baltimore, Maryland.
Click to download photo
|
Photo
Coming
Soon |
R.K. Khosla,
CEO-in-Residence
R.K. Khosla is a serial technology entrepreneur who was most recently the CEO of Peritec Biosciences, a Cleveland Clinic medical device spinout. Khosla has a wide background in finance, entrepreneurship and venture capital. Highlights include two years as a Principal concentrating on wireless technologies at Crystal Ventures, a tech venture fund with $240 million under management with offices in Cleveland, Palo Alto, Singapore & Taipei. He was also CFO and Director of Back Office Operations for All Wound Up which was sold to Borders Group. Khosla started his career at National City in Corporate Banking with the majority of his time being spent in Merchant Banking and Mergers & Acquisitions. Khosla received a BS in Electrical Engineering and Applied Physics with an Economics Minor from Case Western Reserve University and his MBA from Yale.
|
 |
Bill Poore,
Vice President
Bill Poore manages finance and administration functions for both BioEnterprise and BioOhio. The functions include financial projections and statements, grants managements, accounting, personnel administration, and general operations. He brings over 30 years of experience in these areas to BioEnterprise. Poore holds both an MBA in Finance and a BBA in Accounting from Cleveland State University.
Click to download photo
|
|
Photo
Coming
Soon
|
David Ricco,
Director, Business Development
David Ricco focuses on the development of the Cleveland Health-Tech Corridor, recruiting innovative and growing healthcare and technology companies to the geography. Prior to joining BioEnterprise, Ricco was employed by both University Hospitals and Cleveland Clinic facilitating new real estate development and expansion initiatives. He was involved in all aspects of real estate development from due diligence and negotiations to regulatory, environmental, and zoning matters to long-term planning. Ricco received a B.S. degree from The University of Akron and a J.D. degree from Case Western Reserve University.
|
 |
Denise Richardson,
Director, Business Development
Denise Richardson serves as a Director of Business Development, supporting BioEnterprise's strategic initiatives, recruitment of biomedical companies to the region, and the development of a network of resources to support health care company growth. Her corporate experience includes managing the Microbiology laboratory for Mogul Corporation, then a division of Dexter Corp. She was also the Vice President of Regulatory Affairs for United States Biochemical (USB) and Director of Regulatory Affairs for Amersham Pharmacia Biotech. Richardson has worked in research laboratories at the University of California, Santa Barbara (UCSB), Harvard University Medical School, and Eli Lilly. Richardson received her B.S. degree in Microbiology, with highest distinction, from Purdue University, and her M.S. in Marine Biology from Boston University.
Click to download photo
|
.jpg) |
Chris Sklarin,
Director, Business Development
Chris Sklarin focuses on health care service and software companies and is also an Investment Manager with Edison Ventures. He brings over 20 years of experience in product development, sales engineering, and technology investing, having worked in development roles in several software startups as well as over six years in seed investing and venture capital. Most recently he covered the Upper Midwest for Chrysalis Ventures, an early and growth-stage investor in the healthcare and technology sectors, establishing their Cleveland office. While there, he oversaw over $22 million in investment in new and follow-on transactions, including companies in the healthcare services and healthcare informatics sectors. Prior to Chrysalis, he worked for JumpStart, Inc. as an Investment Associate where he specialized in early stage investment analysis and participated in investing over $6 million in 17 companies. Sklarin has a SB in Electrical Engineering from the Massachusetts Institute of Technology and an MBA from the Haas School of Business, University of California at Berkeley.
Click to download photo
|
 |
Karen Spilizewski,
Vice President
Karen Spilizewski is a leader of BioEnterprise's medical device team and is also a Vice President with RiverVest Ventures. She brings nearly 20 years of experience in new product development and business development in medical and non-medical technologies. Spilizewski worked as a business development manager at Avery Dennison and in product development roles ranging from research manager to associate. She was responsible for conducting marketing, financial, technical, and competitive analyses of new opportunities for microelectronic, biomedical, optical display, and MEMs applications. In product development roles, she has developed and commercialized products for various medical devices, including wound care, diagnostics, surgical, and electromedical applications. Spilizewski received her MBA, M.S. in Macromolecular Science and a B.S. degree in Biomedical Engineering from Case Western Reserve.
Click to download photo
|
 |
Laurie Toth,
Marketing Manager
Laurie Toth is the marketing manager at BioEnterprise. In this capacity she performs industry market research, produces the quarterly electronic newsletter, facilitates events and conferences and manages the website and IT systems. Ms. Toth received her BA in Business Administration from Baldwin-Wallace College in Berea, Ohio.
Click to download photo
|
 |
Jim Weisman,
Vice President
Jim Weisman leads BioEnterprise’s efforts in serving and developing start-up health care software and service opportunities. He brings almost 20 years of experience in general management, having worked in senior management at PepsiCo and Macy’s as well as consulting to major financial institutions while with the First Manhattan Consulting Group. Weisman served on the management team of HealthSync, a start-up company developing marketplaces for defined-contribution based corporate sponsored health insurance. He has worked with Glengary Ventures, a fund focused on technology based companies, and provided consulting and executive management services to early-stage companies in the biotech and satellite communications industries. Weisman received his B.S. in Economics from The Wharton School at the University of Pennsylvania and his Executive MBA from Case Weatherhead School of Management.
Click to download photo
|
 |
Adam Yasinow,
Strategic Development Analyst
Adam Yasinow supports BioEnterprise’s strategic development efforts, with a focus on the medical imaging sector. Prior to joining BioEnterprise, Yasinow held internships with the Cleveland Foundation, the Jewish Community Federation of Cleveland and the law firm of Paulette Balin & Associates performing market research, financial analysis and web-based marketing initiatives. He received his B.A. from Washington University in St. Louis.
Click to download photo
|
|
|
|
|
|
|